The analysis revealed that patients with tumours that highly expressed DBN1 mRNA were associated with a shorter time to recurrence, distant metastasis and survival than those with low DBN1 expression (p < 0.05; Figure 4A–C). The gene discussed is DBN1; the disease is neoplasm.